AMORSA THERAPEUTICS INC has a total of 15 patent applications. Its first patent ever was published in 2014. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are IMPHAR AG, TIANJIN TAIPU PHARMACEUTICAL SCI & TECH DEV CO LTD and NASHPHARM.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Australia | 1 | |
#6 | China | 1 | |
#7 | Japan | 1 | |
#8 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Organic chemistry methods |
# | Name | Total Patents |
---|---|---|
#1 | Nivorozhkin Alex | 14 |
#2 | Landrau Nelson | 14 |
#3 | Alex Nivorozhkin | 1 |
#4 | Nelson Landrau | 1 |
Publication | Filing date | Title |
---|---|---|
AU2015343083A1 | Neuro-attenuating ketamine and norketamine compounds, derivatives thereof, and methods | |
CA2922507A1 | Single-layer oral dose of neuro-attenuating ketamine |